Close Menu

NEW YORK – Belgian oncology molecular diagnostics firm Biocartis reported before the opening of the market today that its revenues for the first half of 2019 rose 39 percent year over year, driven by increases in product sales and collaboration revenues.

For the six months ended June 30, Biocartis' revenues rose to €17.1 million ($18.9 million) from €12.3 million in 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US. 

A bipartisan group of senators has introduced a bill seeking increased funding for certain fields, including synthetic biology, ScienceInsider reports. 

Discover magazine writes that paleoproteomics is increasing being used in archaeology, paleoanthropology, and paleontology, including a recent study of a 6,000-year-old ring. 

In Nucleic Acids Research this week: mutagenic effects of ultraviolet "A" light, post-transcription effects of synonymous mutations, and more.